Blood Advances · 2021 · 13 citations · 37 references
Life SciencesBiochemistryMolecular BiologyCell SignalingPost-translational ModificationProtein-protein InteractionsCofactor ChemistryFibrous ProteinsNatural Anticoagulant SystemsProtein Interaction DomainsProtein-protein Interaction ModulationAmino AcidsC-linked GlycosylationCoagulation Factor BindingGlycosylation SitesLaminin BindingPlasma Anticoagulant ActivityProtein-protein Interaction EnhancementTissue Factor Activation
Protein S is a cofactor in the tissue factor pathway inhibitor (TFPI) anticoagulant pathway. It enhances TFPIα-mediated inhibition of factor (F)Xa activity and generation. The enhancement is dependent on a TFPIα-protein S interaction involving TFPIα Kunitz 3 and protein S laminin G-type (LG)-1. C4b binding protein (C4BP), which binds to protein S LG1, almost completely abolishes its TFPI cofactor function. However, neither the amino acids involved in TFPIα enhancement nor the mechanisms underlying the reduced TFPI cofactor function of C4BP-bound protein S are known. To screen for functionally important regions within protein S LG1, we generated 7 variants with inserted N-linked glycosylation attachment sites. Protein S D253T and Q427N/K429T displayed severely reduced TFPI cofactor function while showing normal activated protein C (APC) cofactor function and C4BP binding. Based on these results, we designed 4 protein S variants in which 4 to 6 surface-exposed charged residues were substituted for alanine. One variant, protein S K255A/E257A/D287A/R410A/K423A/E424A, exhibited either abolished or severely reduced TFPI cofactor function in plasma and FXa inhibition assays, both in the presence or absence of FV-short, but retained normal APC cofactor function and high-affinity C4BP binding. The C4BP β-chain was expressed to determine the mechanisms behind the reduced TFPI cofactor function of C4BP-bound protein S. Like C4BP-bound protein S, C4BP β-chain-bound protein S had severely reduced TFPI cofactor function. These results show that protein S Lys255, Glu257, Asp287, Arg410, Lys423, and Glu424 are critical for protein S-mediated enhancement of TFPIα and that binding of the C4BP β-chain blocks this function.
37
Low levels of tissue factor pathway inhibitor (TFPI) increase the risk of venous thrombosis
Anders Erik Astrup Dahm, Astrid van Hylckama Vlieg, Bjørn Bendz et al. · Blood · 2003 · 241 citations · Full text
Medicine, Hematology, Hemostasis +14
Coagulation factor VA2440G causes east Texas bleeding disorder via TFPIα
Lisa M. Vincent, Sinh Tran, Ruzica Livaja et al. · Journal of Clinical Investigation · 2013 · 133 citations · Full text